posted
Any ideas how far this one will go? I've been watching this for good couple weeks. Just wondering if its to late to jump on board. Sure looks like a great play so far!
Posts: 7 | Registered: Mar 2004
| IP: Logged |
posted
What happened, didn't see any news but dropped as much a .33 this morning on no news. Pure profit taking?
Posts: 196 | From: Bradenton, FL | Registered: Nov 2005
| IP: Logged |
posted
yea, it makes me sick to see people cash in early.......this is a mid term hold that will see HUGE gains, i am holding for the LONG
Posts: 404 | From: MS | Registered: Nov 2005
| IP: Logged |
posted
I just bought a few thousand shares. I think its a quality medical team but not much known about efforts other than recent news that the 1st stgae testing proved the techinique around fluicides are safe. I am trying to get a handle on Dr Kristna Menon and his ongoing study at Beth Israel Hospital in Boston. Anyone have anything on that?
Posts: 2 | From: Boston | Registered: Nov 2005
| IP: Logged |
posted
The thing is with NNVC look who they are working with......one of the top rated school in the US!
I buy a few thousands every time the stock dips, it always goes up so I have not lost anything because people KNOW this is a good company.
I bought my first stock when the price was .52 at went to like .30 in a week, that had me scared but I realized THIS COMPANY HAS A DAMN STRONG FOUNDATION, so when it went to .40 I bought my second lot. I now love it when it dips!!
Posts: 404 | From: MS | Registered: Nov 2005
| IP: Logged |
posted
Getting in on this seemed like the thing to do. Looks as if this will keep on giving and I'm sure it will jump some when we have news. At least thats whats happened every other time. This thing is going and going!!!!
Posts: 7 | Registered: Mar 2004
| IP: Logged |
posted
Still raising the bar daily. Does anyone at all know why? I'm holding for sure because NNVC is showing the money. I'm really suprised more are not involved with this one. No pumping intended but this stocks chart speaks for itself.
Posts: 7 | Registered: Mar 2004
| IP: Logged |
posted
Well......I will find the news and post it....they are working with Harvard or the the like and they are through the first trails....I will get it and post it.
Posts: 404 | From: MS | Registered: Nov 2005
| IP: Logged |
posted
UUUUGGGGG...right when I said that it went from .90 to 1.02 !!!!!
missed it.......oh well......suck it up and I will buy when it goes down to 1.00 IF IT DOES...
Posts: 404 | From: MS | Registered: Nov 2005
| IP: Logged |
posted
This thing swings nicely and shows huge gains for those in early. Who knows how long it will last but I don't even get rattled anymore when it drops .15 the track record shows it all. **Holding** is all I can say.
Posts: 7 | Registered: Mar 2004
| IP: Logged |
posted
I love this stock and have made some nice gains from it so far but have a few concerns.
On the company website they give a timeline for their flucide and HIVcide. FDA APPROVAL ISNT EXPECTED UNTIL 2009! Now thats a long time away. They are gonna be hard pressed to find money to fund this thing until the end. Im not questioning their medical team or management i just think this is a long time of development when they dont have anything on the market currently.
In at .18 for 5k shares Out at .7 for 2k Out at 1.20 for 3k In at .8 for 4k
Also..what drove this thing down on the 1st??? Huge volume on no PR...was it bird flu related or what?
Posts: 406 | Registered: Oct 2005
| IP: Logged |
posted
moving again...up around 25%, vulume over 600k...
PR out today:
NanoViricides Collaborates with Vietnam Government to Develop Drug To Treat Bird Flu Virus; Company to receive H5N1 (Avian Flu) biologics from Vietnam MONDAY, JANUARY 09, 2006 8:00 AM - BusinessWire
WEST HAVEN, Conn., Jan 09, 2006 (BUSINESS WIRE) -- NanoViricides, Inc. (Pink Sheets: NNVC) announced today the results of the company's recent trip to Vietnam.
Company officials met with senior officials in the Ministry of Health which resulted in the signing of Memoranda of Understanding (MOU) with governmental agencies responsible for the prevention and treatment of the H5N1 virus. The MOU calls for the government to supply biological materials to Nanoviricides, Inc., which are needed to rapidly develop a drug treatment for avian flu (AviFluCide-I(TM)). The Company believes that other than the US Centers for Disease Control and an international organization based in Europe, no other government or company has been granted access to certain of these biologics.
"Our approach is virus-specific therapy. Having unique access to the H5N1 virus enables us to develop drugs that act directly against this particular virus, whereas other companies are developing drugs against common influenza virus and hoping that some of them may also work against H5N1," said Dr. Anil Diwan, President of Nanoviricides.
Terms of the MOU also call for the collaborative development of a treatment for rabies, a generally fatal disease. The MOU allows these governmental agencies to have an exclusive license to use these drugs for the Vietnamese market.
Eugene Seymour, MD, MPH, CEO of Nanoviricides, Inc., says, "The MOU with Vietnam is a landmark agreement. It will enable Nanoviricides, Inc. to pursue its goal of having AviFluCide-I(TM) tested in overseas facilities, because the company now has access to the current H5N1 strain of the virus. Our operational plan calls for testing to be completed in the next twelve weeks." Dr. Seymour added, "Our system is also perfectly suited to deal with certain potential bioweapon viruses such as Ebola and Marburg. To our knowledge, we have a major head start in the area of targeted anti-viral therapies.
Other Company news:
The Company has issued a "stop transfer" on approximately 3.8 million shares and options held by a former officer and the individuals involved with the "shell company" Edotcom.com, prior to its merger with NanoViricides. The Company will be seeking official and judicial relief as well as seek monetary damages for the harm caused to the Company. The Company will update its shareholders in a separate press release on this matter to be released within the coming days. These actions will help the Company complete its audit and become a reporting company. It is management's goal to meet the requirements necessary to be listed on a major exchange.
ABOUT NANOVIRICIDES, INC.
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for anti-viral therapy. A nanoviricide(TM) is a specially designed, flexible, nanomaterial with or without an encapsulated active pharmaceutical ingredient and a targeting ligand to a specific type of virus, like a guided missile.
This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors including the success of the Company's research and development strategy, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Confused]](confused.gif)
Sure looks like a great play so far!
![[Smile]](smile.gif)
